BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8299650)

  • 21. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoscintigraphic imaging of mIBG-negative metastases in neuroblastoma.
    Berthold F; Waters W; Sieverts H; Linden A
    Am J Pediatr Hematol Oncol; 1990; 12(1):61-2. PubMed ID: 2178460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
    Hausegger KA; Fueger GF; Ebner F; Urban C
    Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.
    Englaro EE; Gelfand MJ; Harris RE; Smith HS
    Radiology; 1992 Feb; 182(2):515-20. PubMed ID: 1732972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
    Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB
    Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI.
    Lebtahi N; Gudinchet F; Nenadov-Beck M; Beck D; Bischof Delaloye A
    J Nucl Med; 1997 Sep; 38(9):1389-92. PubMed ID: 9293795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
    Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
    Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I; Friedman A; Sandler MP; Kedar A
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.
    Munkner T
    Semin Nucl Med; 1985 Apr; 15(2):154-60. PubMed ID: 4001964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
    Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
    Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
    Giammarile F; Lumbroso J; Ricard M; Aubert B; Hartmann O; Schlumberger M; Parmentier C
    Eur J Nucl Med; 1995 Oct; 22(10):1180-3. PubMed ID: 8542903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of radio-iodinated meta-iodo benzyl guanidine in assessment of children with neuroblastoma at NEMROCK.
    Abd El-Aal H
    J Egypt Natl Canc Inst; 2006 Dec; 18(4):375-81. PubMed ID: 18301461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
    Klingebiel T; Reuland P; Feine U; Niethammer D
    Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.